Sildenafil and retinopathy of prematurity risk in very low birth weight infants.

PubWeight™: 0.82‹?›

🔗 View Article (PMID 26491852)

Published in J Perinatol on October 22, 2015

Authors

S Samiee-Zafarghandy1,2,3, J N van den Anker1,2,4,5, M M Laughon6, R H Clark7, P B Smith8,9, C P Hornik8,9, Pharmaceuticals for Children Act – Pediatric Trials Network Administrative Core Committee

Author Affiliations

1: Center for Translational Science, Children's National Medical Center, Washington, DC, USA.
2: Division of Clinical Pharmacology, Children's National Medical Center, Washington, DC, USA.
3: Department of Pediatrics, McMaster University Medical Center, Hamilton, ON, Canada.
4: Intensive Care, Erasmus Medical Center-Sophia Children's Hospital, Rotterdam, The Netherlands.
5: Department of Paediatric Pharmacology, University Children's Hospital Basel, Basel, Switzerland.
6: Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill, NC, USA.
7: Pediatrix-Obstetrix Center for Research and Education, Sunrise, FL, USA.
8: Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA.
9: Department of Pediatrics, Duke University School of Medicine, Durham, NC, USA.

Articles cited by this

Variable selection for propensity score models. Am J Epidemiol (2006) 10.68

The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol (2005) 10.63

Matching using estimated propensity scores: relating theory to practice. Biometrics (1996) 6.73

New intrauterine growth curves based on United States data. Pediatrics (2010) 3.72

The effects of sildenafil citrate on choroidal thickness as determined by enhanced depth imaging optical coherence tomography. Retina (2011) 2.12

Effects of sildenafil citrate on human hemodynamics. Am J Cardiol (1999) 1.86

Sildenafil (Viagra) associated anterior ischemic optic neuropathy. Arch Ophthalmol (2000) 1.67

Emerging role of sildenafil in neonatology. Indian Pediatr (2011) 1.43

Safety of sildenafil in infants*. Pediatr Crit Care Med (2014) 1.42

Anterior ischemic optic neuropathy associated with viagra. J Neuroophthalmol (2001) 1.34

Medication use in the neonatal intensive care unit. Am J Perinatol (2013) 1.28

Retinal effects of 6 months of daily use of tadalafil or sildenafil. Arch Ophthalmol (2009) 1.20

The effect of sildenafil on ocular blood flow. Br J Ophthalmol (2008) 1.20

Pupil-sparing third nerve palsy associated with sildenafil citrate (Viagra). Am J Ophthalmol (1998) 1.16

Are phosphodiesterase type 5 inhibitors associated with vision-threatening adverse events? A critical analysis and review of the literature. J Sex Med (2011) 1.07

The pathophysiology of retinopathy of prematurity: an update of previous and recent knowledge. Acta Ophthalmol (2013) 1.05

Severe retinopathy of prematurity (ROP) in a premature baby treated with sildenafil acetate (Viagra) for pulmonary hypertension. Br J Ophthalmol (2004) 1.03

Vision disorders and phosphodiesterase type 5 inhibitors: a review of the evidence to date. Drug Saf (2009) 1.00

Expression of the PDE5 enzyme on human retinal tissue: new aspects of PDE5 inhibitors ocular side effects. Eye (Lond) (2007) 0.97

Effect of sildenafil citrate on intraocular pressure and blood pressure in human volunteers. Exp Eye Res (2011) 0.95

Ocular findings of oral sildenafil use in term and near-term neonates. J AAPOS (2010) 0.92

The effect of sildenafil on retinopathy of prematurity in very preterm infants. J Perinatol (2012) 0.88

Do current retinopathy of prematurity screening guidelines miss the early development of pre-threshold type 1 ROP in small for gestational age neonates? Eye (Lond) (2007) 0.83

Sildenafil causes a dose- and time-dependent downregulation of phosphodiesterase type 6 expression in the rat retina. Int J Impot Res (2000) 0.77